Crossmark

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data

Crossref DOI link: https://doi.org/10.1186/s12886-018-1006-9

Published Online: 2018-12-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Muston, Dominic

Korobelnik, Jean-Francois

Reason, Tim

Hawkins, Neil

Chatzitheofilou, Ismini

Ryan, Fay

Kaiser, Peter K.
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 22 June 2018

Accepted: 10 December 2018

First Online: 27 December 2018

Ethics approval and consent to participate

: All included trials had protocols approved by relevant country- and trial-specific institutional review boards/independent ethics committees.

: Not applicable.

: The authors have the following financial competing interests to declare:Dominic Muston is a former employee of Bayer.Jean-Francois Korobelnik is a consultant for Alcon, Allergan, Bayer, Kanghong, Novartis, and Roche.Tim Reason, Ismini Chatzitheofilou, and Fay Ryan are employees of QuintilesIMS, which was funded by Bayer to undertake the project on which this article is based.Neil Hawkins is a consultant for Bayer.Peter Kaiser is a consultant for Alcon, Allergan, Bayer, Kanghong, Novartis, and Regeneron.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below